SCOTT D SANDELL Insider Trading $INHX INHIBITEX, INC.
Get free email notifications about insider trading for SCOTT D SANDELL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SCOTT D SANDELL. SCOTT D SANDELL is 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Marker Therapeutics, Inc. ($MRKR) and 10% Owner in ZTI MERGER SUBSIDIARY III INC ($ZHNE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and in MYOGEN INC ($MYOG) and 10% Owner in MYOGEN INC ($MYOG) and in PHARMION CORP ($PHRM) and 10% Owner in PHARMION CORP ($PHRM) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in Vitae Pharmaceuticals, Inc ($VTAE) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in Liquidia Technologies Inc ($LQDA) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in INTERCELL USA, INC. ($IOMI) and 10% Owner in INNERWORKINGS INC ($INWK) and 10% Owner in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in MULESOFT, INC ($MULE) and Director in Data Domain, Inc. ($DDUP) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Cloudflare, Inc. ($NET) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Sprout Social, Inc. ($SPT) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Elastic N.V. ($ESTC) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Surface Oncology, Inc. ($SURF) and Director in Bloom Energy Corp ($BE) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX).
SCOTT D SANDELL in INHIBITEX, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SCOTT D SANDELL: 10% Owner
Holdings: 6,898,294 shares
Latest Transaction: Oct 30 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SCOTT D SANDELL in INHIBITEX, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ADAP, AKUS, APPN, ARDM, ABIO, ARDX, AVEO, BE, CRCM, CASC, CBIO, CERC, NET, DDUP, EAR, ESTC, EPZM, GNCA, GLYC, HPTX, INHX, INWK, INZY, IOMI, ILIU, LIQDA, MRKR, MRSN, MTCR, MIRM, MULE, MYOG, NKTX, PRTK, PHRM, RARX, RGLS, RYTM, ROKA, SPT, SUPN, SURF, SYBX, TSRO, TCON, TRVI, VTAE, VG, ZHNE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 30 2009 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 1.46 | 791,015 | 1,154,882 | 791,015 | |
| Oct 30 2009 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 1.46 | 263,671 | 384,960 | 263,671 | |
| Oct 30 2009 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 1.28 | 1,757,812 | 2,249,999 | 6,898,294 | 5.1 M to 6.9 M (+34.20 %) |
| Oct 30 2009 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 1.28 | 585,937 | 749,999 | 1,941,407 | 1.4 M to 1.9 M (+43.23 %) |
| Nov 12 2004 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 8.81 | 581,391 | 5,122,055 | 581,391 | |
| Nov 12 2004 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 7.34 | 1,937,970 | 14,224,700 | 6,495,952 | 4.6 M to 6.5 M (+42.52 %) |
| Jun 09 2004 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 2,284,263 | 0 | 0 | |
| Jun 09 2004 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 6,017,132 | 0 | 0 | |
| Jun 09 2004 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Option Exercise | J | 0.00 | 946,827 | 0 | 6,017,132 | |
| Jun 09 2004 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 3,487,982 | 0 | 4,557,982 | 1.1 M to 4.6 M (+325.98 %) |
| Jun 07 2004 | INHX | INHIBITEX, INC. | SANDELL SCOTT D | 10% Owner | Buy | P | 7.00 | 1,070,000 | 7,490,000 | 1,070,000 | 0 to 1.1 M |
Page: 1